Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells

Carcinogenesis

Volumn 26, Issue 11, 2005, Pages 1988-1998

  Parhamifar, Ladan ^a   Jeppsson, Bengt ^a   Sjölander, Anita ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE D4; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PROTEIN KINASE C; SIGNAL PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA;

ARTICLE; CANCER GROWTH; CELL CULTURE; CELL FRACTIONATION; CELL LINE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GEL ELECTROPHORESIS; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; CELL NUCLEUS; COLON TUMOR; COMPARATIVE STUDY; CYTOLOGY; CYTOSOL; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; PROTEIN TRANSPORT;

CALCIUM; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; COLONIC NEOPLASMS; CYTOSOL; ENZYME ACTIVATION; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; INTESTINAL MUCOSA; LEUKOTRIENE D4; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHOLIPASES A; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN TRANSPORT;

EID: 27844451525     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi159     Document Type: Article

References (49)

1. 1 receptor. Nature, 399, 789-793.
2. Heise,C.E., O'Dowd,B.F., Figueroa,D.J. et al. (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem., 275, 30531-30536.
3. Funk,C.D. (2001) Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science, 294, 1871-1875.
4. Serhan,C.N., Haeggström,J.Z. and Leslie,C.C. (1996) Lipid mediator networks in cell signaling: Update and impact of cytokines. FASEB J., 10, 1147-1158.
5. Öhd,J.F., Wikström,K. and Sjölander,A. (2000) Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology, 119, 1007-1018.
6. 4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. J. Biol. Chem., 278, 45577-45585.
7. 1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology, 124, 57-70.
8. 1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res., 65, 732-742.
9. Balkwill,F. and Mantovani,A. (2001) Inflammation and cancer: Back to Virchow? Lancet, 357, 539-545.
10. Coussens,L.M. and Werb,Z. (2002) Inflammation and cancer. Nature, 420, 860-867.
11. Ekbom,A., Helmick,C., Zack,M. and Adami,H.O. (1990) Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med., 323, 1228-1233.
12. Greten,F.R., Eckmann,L., Greten,T.F., Park,J.M., Li,Z.W., Egan,L.J., Kagnoff,M.F. and Karin,M. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
13. 2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation. Cytokine, 11, 104-110.
14. Pikarsky,E., Porat,R.M., Stein,I. et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature, 431, 461-466.
15. 2: mediators of inflammation, proliferation and apoptosis. Prog. Lipid. Res., 40, 167-197.
16. 2 in eicosanoid generation. Am. J. Respir. Crit. Care Med., 161, S32-S35.
17. 2. J. Biol. Chem., 269, 13057-13060.
18. 2-alpha and COX-1 with the Golgi apparatus of A549 human lung epithelial cells. J. Cell Sci., 116, 2303-2310.
19. 2 but not the gamma isoform in Ehrlich ascites tumor cells. Eur. J. Biochem., 267, 5531-5539.
20. 2. J. Biol. Chem., 274, 5163-5169.
21. 2 in human colorectal cancer. Anticancer Res., 18, 3283-3287.
22. 2 via its high affinity receptor stimulates extracellular matrix invasion by normal and cancer cells. J. Biol. Chem., 272, 2346-2353.
23. Garcia-Rodriguez,L.A. and Huerta-Alvarez,C. (2001) Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology, 12, 88-93.
24. 2 mRNA expression: A novel mechanism for acetylsalicylic acid-mediated growth inhibition and apoptosis in colon cancer cells. Regul. Pept., 114, 101-107.
25. Prescott,S.M. and Fitzpatrick,F.A. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta, 1470, M69-78.
26. 2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology, 36, 363-373.
27. 2 suppresses Apc(Min)-induced tumorigenesis. Proc. Natl Acad. Sci. USA, 98, 3935-3939.
28. 2 expression in tumours: a target for therapeutic intervention? Drug Discov. Today, 8, 710-716.
29. Henle,G. and Deinhardt,F. (1957) The establishment of strains of human cells in tissue culture. J. Immunol., 79, 54-59.
30. Fogh,J., Orfeo,T., Tiso,J. and Sharkey,F.E. (1979) Establishment of human colon carcinoma lines in nude mice. Exp. Cell Biol., 47, 136-144.
31. 2 Group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells. J. Biol. Chem., 279, 48550-48561.
32. 2-alpha in the EA.hy.926 human endothelial cell line is proliferation dependent and modulated by phosphorylation. J. Cell Sci., 115, 4533-4543.
33. 2 by m3 and m2 receptors. Am. J. Physiol. Gastrointest Liver Physiol., 284, G472-480.
34. 4 activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J. Cell Sci., 115, 1883-1893.
35. 4-induced calcium signal in human intestinal epithelial cells. Exp. Cell Res., 262, 95-103.
36. 2+ mobilisation and ERK1/2 activation. Exp. Cell Res., 302, 31-39.
37. 2+-dependent apoptosis through the mitochondrial pathway. J. Biol. Chem., 279, 25219-25225.
38. Lim,H.Y., Joo,H.J., Choi,J.H., Yi,J.W., Yang,M.S., Cho,D.Y., Kim,H.S., Nam,D.K., Lee,K.B. and Kim,H.C. (2000) Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res., 6, 519-525.
39. Smalley,W.E. and DuBois,R.N. (1997) Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol., 39, 1-20.
40. 2 by phosphatidylinositol bisphosphate levels. J. Immunol., 164, 5398-5402.
41. Lai,W.C., Zhou,M., Shankavaram,U., Peng,G. and Wahl,L.M. (2003) Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol., 170, 6244-6249.
42. Dupre,D.J., Le Gouill,C., Gingras,D., Rola-Pleszczynski,M. and Stankova,J. (2004) Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1. J. Pharmacol. Exp. Ther., 309, 102-108.
43. Milligan,G. (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective. Mol. Pharmacol., 64, 1271-1276.
44. Wang,D., Raehal,K.M., Bilsky,E.J. and Sadee,W. (2001) Inverse agonists and neutral antagonists at mu opioid receptor (MOR): Possible role of basal receptor signaling in narcotic dependence. J. Neurochem., 77, 1590-1600.
45. 2alpha level in rat PC12 cells. Neurosci. Lett., 365, 218-222.
46. 2 gene. Nucleic Acids Res., 22, 5093-5098.
47. 2 and fatty acids in human colon tumours and associated normal tissue. Eur. J. Cancer, 32A, 1781-1787.
48. 2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis, 24, 307-315.
49. 2 inhibitors on proliferation and apoptosis of murine intestinal cells. J. Surg. Res., 84, 51-56.